Ryder System, Inc. logo R - Ryder System, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 21
HOLD 13
SELL 0
STRONG
SELL
0
| PRICE TARGET: $282.14 DETAILS
HIGH: $320.00
LOW: $245.00
MEDIAN: $285.00
CONSENSUS: $282.14
UPSIDE: 17.41%

Stock News

Tenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026

Tenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026

~Newly issued patents continue to solidify the company's position as an innovator in the rapidly growing sacro-pelvic fusion market~ ~Portfolio now includes 38 issued U.S. patents and 9 international patents, with 31 applications pending~ ~Company anticipates continued additions to its IP portfolio along with several product launches in the coming quarters~ LOS GATOS, CA / ACCESS Newswire / October 15, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients suffering from certain sacro-pelvic disorders, today announced that the U.S. Patent and Trademark Office (USPTO) has issued 8 new patents to the Company so far in 2026 fiscal year. With these additions, Tenon holds 38 issued U.S. patents and 9 international patents and has 31 U.S. and foreign patent applications pending.

Oct 15, 2026 04:30 AM • accessnewswire.com
What healthcare CEO Kate Ryder of Maven is telling her kids every day amid the AI education threat

What healthcare CEO Kate Ryder of Maven is telling her kids every day amid the AI education threat

Maven CEO and founder Kate Ryder tells Julia Boorstin during the latest "CNBC Changemakers" podcast that the health benefits firm was close to maxing out its full-year budget for AI use by August. She says overall return on investment remains unproven, but she has no doubts about how transformative the technology will be, especially in women's healthcare where data has long been lacking.

Oct 14, 2026 08:25 AM • cnbc.com
Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal

Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal

Engagement with leading orthopedic surgeons and cartilage repair specialists highlights growing awareness of GelrinC's off-the-shelf regenerative technology GelrinC is CE Mark approved in Europe, where Regentis is expanding its network of Centers of Excellence to support surgeon training and commercialization efforts European clinical sites also support the Company's ongoing U.S. FDA pivotal Phase III trial HERZLIYA, ISRAEL / ACCESS Newswire / October 12, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced strong interest and engagement from orthopedic surgeons, physicians and cartilage repair specialists who visited the Company's booth at the 8th International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit, held October 8-10, 2026, in Porto, Portugal.

Oct 12, 2026 05:00 AM • accessnewswire.com
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

Second of Four Planned Modules Moves Rolling FDA Review Forward Advances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027 White Bear Lake, Minnesota--(Newsfile Corp. - October 12, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced the submission of the second module of its Modular Premarket Approval ("PMA") application to the U.S. Food and Drug Administration ("FDA") for the Acclaim® cochlear implant, which has received FDA Breakthrough Device Designation. The second module, which included primarily engineering information, follows the Company's submission of the first module on June 30, 2026.

Oct 12, 2026 04:30 AM • newsfilecorp.com
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers

DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers

Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policy TAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc . (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company vertically integrating its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that its recently acquired CLIA-certified precision oncology laboratory subsidiary Helomics Corporation has received a Medicaid coverage determination in gynecologic cancers for the ChemoFx® Assay, a commercially available chemoresponse test that measures how a patient's live tumor cells respond to chemotherapy agents, in gynecologic cancers.

Oct 12, 2026 02:00 AM • accessnewswire.com
Ryder Declares Quarterly Cash Dividend

Ryder Declares Quarterly Cash Dividend

MIAMI--(BUSINESS WIRE)--The Board of Directors of Ryder System, Inc. (NYSE: R) declared a regular quarterly cash dividend of $1.01 per share of common stock to be paid on December 18, 2026 to shareholders of record on November 23, 2026. This is Ryder's 201st consecutive quarterly cash dividend – marking 50 years of uninterrupted dividend payments. About Ryder System, Inc. Ryder System, Inc. (NYSE: R) is a nearly $13 billion leading provider of outsourced logistics and transportation services th.

Oct 09, 2026 12:30 PM • businesswire.com
Jackpot Digital and Pechanga Resort Casino Launch Eight Jackpot Blitz(R) Poker Tables, Ushering in Next Generation Poker

Jackpot Digital and Pechanga Resort Casino Launch Eight Jackpot Blitz(R) Poker Tables, Ushering in Next Generation Poker

--Ribbon Cutting and Guest Giveaways Mark Kickoff for Largest Single-property Jackpot Blitz(R) Deployment to Date, Now Open for Play-- Vancouver, British Columbia and Temecula, California--(Newsfile Corp. - October 9, 2026) - Jackpot Digital Inc. (TSXV: JJ) (OTCQB: JPOTF) (Frankfurt Stock Exchange: LVH3) ("Jackpot Digital" or the "Company"), the world's leading manufacturer of dealerless multiplayer electronic poker tables, and Pechanga Resort Casino, one of North America's largest and most respected Tribal gaming destinations, are pleased to jointly announce that eight (8) Jackpot Blitz® electronic poker tables are now open for play at Pechanga Resort Casino, located just outside of Temecula, California. Jackpot Digital and Pechanga Resort Casino Executive and Board Members Cut the Ribbon Marking the Opening of 8 New Digital Poker Games at Pechanga Resort Casino Outside Temecula, Calif.

Oct 09, 2026 03:18 AM • newsfilecorp.com
Theralase(R) to Present at ThinkEquity Conference

Theralase(R) to Present at ThinkEquity Conference

Toronto, Ontario--(Newsfile Corp. - October 9, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research and development of proprietary Energy-Activated Small Molecules ("EASMs") for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that the Company has been invited to present at the 2026 ThinkEquity Conference in New York. ThinkEquity is a boutique investment bank that has collectively financed over $50 billion of public and private capital raises, restructurings, mergers and acquisitions.

Oct 09, 2026 03:00 AM • newsfilecorp.com
ODYSSEY(R) Battery Joins NFI Empire's Project REBORN, Providing Premium Battery Technology to Support The Brett Boyer Foundation

ODYSSEY(R) Battery Joins NFI Empire's Project REBORN, Providing Premium Battery Technology to Support The Brett Boyer Foundation

Powering Every New Beginning: ODYSSEY® Battery Energizes Project REBORN's Mission NORTH EAST, PA / ACCESS Newswire / October 8, 2026 / NFI Empire, a fully owned subsidiary of Newport Gold, Inc. (OTCID:NWPG), today announced that ODYSSEY® Battery has joined Project Reborn-001 as a key technology partner. The custom vehicle build is heading to auction at The Red Bird Games in Brentwood, TN, with proceeds benefiting The Brett Boyer Foundation.

Oct 08, 2026 07:25 AM • accessnewswire.com

Price Targets